Literature DB >> 30008945

The tumor suppressor role of miR-155-5p in gastric cancer.

Shiqing Li1, Tao Zhang1, Xiaoqing Zhou1, Zonghan Du1, Fumin Chen1, Jun Luo1, Qingsong Liu2.   

Abstract

Gastric cancer (GC) is the fifth most common type of malignant tumor worldwide and the most common cause of cancer-associated mortality in China. Recent studies revealed that microRNAs (miRNAs) function in the pathogenesis of GC, and that miR-155-5p expression is downregulated in GC tissues. However, the function of miR-155-5p has not been fully identified. In the present study, it was demonstrated that overexpression of miR-155-5p inhibited GC-cell proliferation and promoted apoptosis, while downregulation of miR-155-5p promoted GC-cell proliferation and decreased the cisplatin sensitivity of GC cells. Mitogen-activated protein kinase kinase kinase 10 was demonstrated to be a potential target gene of miR-155-5p. In conclusion, an antitumor role of miR-155-5p in gastric cancer was suggested.

Entities:  

Keywords:  apoptosis; gastric cancer; microRNA-155-5p; proliferation

Year:  2018        PMID: 30008945      PMCID: PMC6036547          DOI: 10.3892/ol.2018.8932

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Authors:  Dong Li; Xingguang Liu; Li Lin; Jin Hou; Nan Li; Chunmei Wang; Pin Wang; Qian Zhang; Peng Zhang; Weiping Zhou; Zhengxin Wang; Guoshan Ding; Shi-Mei Zhuang; Limin Zheng; Wenzhao Tao; Xuetao Cao
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

2.  The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.

Authors:  Hailong Li; Shoupin Xie; Min Liu; Zhaofeng Chen; Xiaojun Liu; Li Wang; Dayan Li; Yongning Zhou
Journal:  Int J Oncol       Date:  2014-05-06       Impact factor: 5.650

Review 3.  MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

Authors:  Silvia Giordano; Amedeo Columbano
Journal:  Hepatology       Date:  2012-12-26       Impact factor: 17.425

4.  Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death.

Authors:  S Bhattacharya; A M Chalk; A J M Ng; T J Martin; A C Zannettino; L E Purton; J Lu; E K Baker; C R Walkley
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

5.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

6.  Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs.

Authors:  David M Garcia; Daehyun Baek; Chanseok Shin; George W Bell; Andrew Grimson; David P Bartel
Journal:  Nat Struct Mol Biol       Date:  2011-09-11       Impact factor: 15.369

7.  microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.

Authors:  Dong-liang Chen; Dong-sheng Zhang; Yun-xin Lu; Le-zong Chen; Zhao-lei Zeng; Ming-ming He; Feng-hua Wang; Yu-hong Li; Hui-zhong Zhang; Helene Pelicano; Wei Zhang; Rui-hua Xu
Journal:  Oncotarget       Date:  2015-05-10

8.  MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.

Authors:  Xiaoxiao Ge; Xinyang Liu; Fengjuan Lin; Peng Li; Kaiyi Liu; Ruixuan Geng; Congqi Dai; Ying Lin; Wenbo Tang; Zheng Wu; Jinjia Chang; Jianwei Lu; Jin Li
Journal:  Oncotarget       Date:  2016-04-26

9.  Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.

Authors:  Qi Zhou; Yanni Yu
Journal:  Med Sci Monit       Date:  2015-11-07

10.  miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.

Authors:  Mengchu Zhu; Mei Wang; Fang Yang; Yiqing Tian; Jie Cai; Huan Yang; Hailong Fu; Fei Mao; Wei Zhu; Hui Qian; Wenrong Xu
Journal:  Oncotarget       Date:  2016-03-29
View more
  8 in total

Review 1.  Clinical crosstalk between microRNAs and gastric cancer (Review).

Authors:  Jing Ouyang; Zhizhong Xie; Xiaoyong Lei; Guotao Tang; Runliang Gan; Xiaoyan Yang
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

2.  Modulation in the microRNA repertoire is responsible for the stage-specific effects of Akt suppression on murine neuroendocrine prostate cancer.

Authors:  Abdulrahman Alwhaibi; Fei Gao; Sandeep Artham; Bernard M Hsia; Ashis Mondal; Ravindra Kolhe; Payaningal R Somanath
Journal:  Heliyon       Date:  2018-09-17

3.  Differential expression of miRNAs involved in biological processes responsible for inflammation and immune response in lichen sclerosus urethral stricture disease.

Authors:  Harjivan Kohli; Brandon Childs; Travis B Sullivan; Artem Shevtsov; Eric Burks; Thomas Kalantzakos; Kimberly Rieger-Christ; Alex J Vanni
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

4.  Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer.

Authors:  Songna Wang; Yuan Fu; Kudelaidi Kuerban; Jiayang Liu; Xuan Huang; Danjie Pan; Huaning Chen; Yizhun Zhu; Li Ye
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

5.  Neutrophil Transcriptional Deregulation by the Periodontal Pathogen Fusobacterium nucleatum in Gastric Cancer: A Bioinformatic Study.

Authors:  Ting Zhou; Xianhong Meng; Daxiu Wang; Weiran Fu; Xinrui Li
Journal:  Dis Markers       Date:  2022-08-18       Impact factor: 3.464

6.  Helicobacter pylori CagA Protein Regulating the Biological Characteristics of Gastric Cancer through the miR-155-5p/SMAD2/SP1 axis.

Authors:  Leilei Wu; Fei Jiang; Xiaobing Shen
Journal:  Pathogens       Date:  2022-07-28

7.  Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes.

Authors:  Chengyao Wan; Jing Wen; Ying Huang; Hongying Li; Wenqi Wu; Qiongni Xie; Xiaolin Liang; Zhongyuan Tang; Weihua Zhao; Peng Cheng; Zhenfang Liu
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

Review 8.  Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID.

Authors:  Giuliana Amato; Federica Vita; Paolina Quattrocchi; Paola Lucia Minciullo; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.